Prodeon Medical Completes Enrollment for Expander-2 Pivotal Trial
Prodeon Medical, Inc. has successfully completed patient enrollment for its Expander-2 Pivotal Trial, evaluating the safety and efficacy of the Urocross® Expander System for treating lower urinary tract symptoms due to benign prostatic hyperplasia.
© Copyright 2025. All Rights Reserved by MedPath